[ad_1]
In the Altai Territory (RF) Three doctors were infected with COVID-19who were previously vaccinated against the coronavirus with the Russian vaccine “Sputnik V”.
So far, three doctors have confirmed a new infection. of 42who were vaccinated. This was reported on the website of the regional Ministry of Health.
The drug consists of two components: three weeks after the first injection, the person receives the second. A person is considered vaccinated only three weeks after the second vaccination, since all this time there is a process of immunity formation, explained the Ministry of Health.
The agency suggested that Russians who had received the vaccine did not have time to build up immunity to the coronavirus at the time of contact with the COVID-19 pathogen. “This alone could have caused the infection of the doctors.”, – believes in the regional ministry of health.
It is known that a test batch of the Sputnik V vaccine against COVID-19 reached the Altai territory in late September.
The first person to be vaccinated was the chief epidemiologist of the region, Irina Pereladova. After her, the vaccine would be delivered to 41 more health workers from different organizations in Barnaul.
According to the Altai Territory headquarters for the fight against coronavirus infection, during the entire period of the pandemic in the region, 21,499 people were infected, of which 18,090 recovered, 900 died.
Coronavirus distribution map in the world:
We will remember, the first in the world to register a vaccine against the coronavirus – “Sputnik V” – said Russia. The drug was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and underwent clinical trials in June and July.
However, in the West there was criticism of the Russian drug, because the vaccine was approved without large-scale data from the third phase of trials, in which several thousand subjects would participate.
As OBOZREVATEL wrote, the number of deaths from coronavirus infection in Europe has exceeded 300,000, and this number will grow as winter approaches.
